Eric Lefkofsky Is on a Mission to Find a Cure for Cancer

Eric Lefkofsky knows how to create a successful startup. He has taken a number of startups public, and managed to make a lot of money along the way. As such, he is an undisputed tech founder that is making an impact on the world. Unfortunately, his wife received a cancer diagnosis and his mission in life changed. A cancer diagnosis can be devastating, even confusing. Once over the shock, people often look for answers that are elusive. Those suffering from blood cancer along with their loved ones end up with far more questions than answers.

Lefkofsky has channeled his genius into taking a data-driven approach to curing cancer. The secret is learning to leverage machine learning and genomic sequencing to understand a patient’s tumor growth. It is disruptive technology, and positions itself to change how the medical industry peers inside the human body at a molecular level. There will come a time when doctors will be able to guide medicine applications and treatments with precision.

Even a professional like Lefkofsky strains at the thought of managing a new startup. However, Tempus, his new company, was born out of a personal problem that begged for a solution. His education offers some insights as to why he is able to bring ideas to fruition. Eric Lefkofsky presently serves as an adjunct professor at the University of Chicago. He graduated from the University of Michigan and went on to receive a Juris Doctor from the University of Michigan Law School. He has a gifted mind that utilizes his diverse education experience.

Lefkofsky is also worth $1.7 billion dollars. As such, he is more than willing to put hundreds of millions of dollars of his own money into projects. This gives him an edge that positions him to be a mover and shaker in the world.

To know more visit @: chicago.curbed.com/2015/1/6/10005148/groupon-ceo-eric-lefkofsky-the-man-behind-195m-home-sale